Please welcome returning guest, Dr. Ruchir Patel, a board-certified sleep medicine physician, entrepreneur, and consultant with over 15 years of experience in sleep medicine and neuromodulation. Dr. Patel is recognized for his deep expertise in both medical devices and advanced therapies for sleep disorders. He’s the founder of a multi-location sleep medicine practice, has worked extensively with transcranial magnetic stimulation, and has consulted for companies at the forefront of sleep technology—including Zoll, the maker of the Remede device. Most recently, Dr. Patel has taken on the role of Vice President and Senior Medical Director at Inspire Medical Systems, Inc., the company behind the hypoglossal nerve stimulator for obstructive sleep apnea (OSA).

In this episode, we’re diving into the evolving field of neuromodulation for sleep apnea, discussing both obstructive sleep apnea (OSA) and central sleep apnea (CSA). Dr. Patel’s unique clinical experience spans the use of Inspire therapy for OSA and Remede for CSA, making him a true leader in the integration of device-based therapies for complex sleep disorders.

Today’s conversation is sponsored by Inspire Medical Systems, Inc., whose support helps us continue exploring these important innovations in sleep medicine. We’ll be breaking down how hypoglossal nerve stimulation works for OSA, what makes it an alternative for patients who can’t tolerate CPAP, and how transvenous phrenic nerve stimulation is opening new doors for those with CSA. Whether you’re a clinician, a patient, or simply passionate about sleep health, you’ll gain valuable insights into the current and future landscape of neuromodulation in sleep medicine.

For more information on Inspire therapy for Hypoglossal Nerve Stimulation, watch this episode with Dr. Ahmad Mahmoud here: youtu.be/IT9pmqelmtM?si=yinCaF9bQy0qz-0L